Biomarkers & Clinical Trial Advances in Ovarian Cancer

from Connect Ovar Coffee · host OVARCOME

We sit down on this episode to Connect Ovar Coffee with with Global Expert Dr. Angeles Secord, the Lead Investigator of the RINA-S trial, the former President of the Society of Gynecologic Oncology and Professor, Gynecologic Oncology, at Duke University Cancer Center, to talk about: 1. Biomarkers - established, emerging, and in the pipeline 2. Clinical Trials, focusing on RINA - S3. ADCs 4. Combination Therapies 5. + Much More

Episode metadata supplied by the publisher feed · Published Jun 9, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Biomarkers & Clinical Trial Advances in Ovarian Cancer

0:00 59:49

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Connect Ovar Coffee?

This episode is 59 minutes long.

When was this Connect Ovar Coffee episode published?

This episode was published on June 9, 2026.

Can I download this Connect Ovar Coffee episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!